ReviewCurrent opinion in allergy and clinical immunology2016

Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs.

Gilda Varricchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.